Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
HIL sustains momentum, delivers resilient financial performance with significant improvement in revenue as well as profitability - The Pharma Times | Pharma & Health Care News Portal
Archives

HIL sustains momentum, delivers resilient financial performance with significant improvement in revenue as well as profitability

National, New Delhi, March 09, 2019: HIL Limited, one of the India’s largest manufacturers and sellers of fibre cement roofing and green building products, today announced the financial results for the quarter and nine months ended December 31, 2018. Part of the USD 2.5 billion CK Birla Group, the company’s revenues for the current quarter stood at Rs. 326 crore as against Rs. 282 crore for the same period of last year showing growth of 16%. For the first 9 months of current year, revenues stood at Rs. 1130 crore as against Rs. 943 crore for the same period of last year (Growth of 20%). Please note that nine months revenue of last year is net of duties and taxes on sale of goods for comparison purpose. Sales driven by building solutions delivered continuous growth quarter on quarter. Strong growth continues to come from Plumbing Solutions with 121% year-on-year growth during Q3 FY19 and 132% year-on-year growth during the nine months period. We are seeing traction in Birla Aerocon range given the emphasis on solutions-based approach.

Business performance highlights:

For the first 9 months of the year, Profit before Tax improved by 49% year-on-year to Rs.134crore.  In Q3 FY19 Profit before Tax stood to Rs. 13.5 crore. The PBT is lowered during the quarter on account of reversal of Forex gain of Rs.7.5 crore booked in Q2FY19 on Euro 20 million loan given to wholly owned subsidiary in Germany for purchase of shares of Parador Holdings GmbH

  • This performance has been supported by growth in sales across board, where initiatives taken to drive higher productivities from operations driving earnings
  • Emphasis on enhancing financial parameters have resulted in expansion of pre-tax earnings
  • Contained borrowings and optimal working capital management will allow transmission of growth realised into higher net profits going forward

Mr. Dhirup Roy Choudhary, Managing Director, HIL Limited said, “HIL has posted another set of robust numbers this quarter. The significant rise in profits has been owning to a committed performance from all our employees backed by an ever-daunting loyalty from our dealers. All our SBUs have grown more than the segments they operate in. Our roofing solution business under brand Charminar and building solution business under brand Birla Aerocon has maintained its leadership positions. Our efforts towards developing a brand pull and channel development supported by a continuous effort of launching new product ranges has propelled this growth.”

Corporate Comm India(CCI Newswire)
The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

5 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

7 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

3 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago